​

Esperion Therapeutics Ownership | Who Owns Esperion Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Esperion Therapeutics Ownership Summary

Esperion Therapeutics is owned by 27.59% institutional investors, 0.44% insiders, and 71.98% retail investors. Blackrock is the largest institutional shareholder, holding 8.26% of ESPR shares. BB Biotech AG Ord is the top mutual fund, with 5.05% of its assets in Esperion Therapeutics shares.

ESPR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEsperion Therapeutics27.59%0.44%71.98%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.16%11.89%61.94%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock13.98M8.26%$31.04M
Blackrock funding, inc. /de14.83M7.54%$39.31M
Vanguard group12.09M6.14%$32.04M
Two seas capital lp9.75M4.95%$25.84M
Wasatch advisors lp7.06M3.59%$18.71M
Penderfund capital management6.68M3.39%$17.69M
Geode capital management4.75M2.41%$12.59M
State street4.48M2.28%$11.87M
Meditor group3.79M2.24%$8.42M
Morgan stanley4.06M2.06%$10.75M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Meditor group3.79M15.57%$8.42M
Penderfund capital management6.68M2.98%$17.69M
Aigh capital management3.00M2.24%$7.95M
Two seas capital lp9.75M0.41%$25.84M
Integral health asset management1.50M0.27%$3.98M
Diametric capital, lp236.15K0.23%$625.78K
Summit wealth group323.00K0.21%$855.95K
Logos global management lp750.00K0.18%$1.99M
Arrowpoint investment partners (singapore) pte.40.49K0.11%$107.29K
Wasatch advisors lp7.06M0.10%$18.71M

Top Buyers

HolderShares% AssetsChange
Blackrock13.98M0.00%11.14M
Nuveen3.71M0.00%3.29M
Morgan stanley4.06M0.00%3.00M
Aigh capital management3.00M2.24%3.00M
Royce & associates lp2.29M0.06%2.29M

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---13.71M
Bellevue group---9.69M
Great point partners---5.79M
Bank of america corp /de/1.16M0.00%-3.38M
Wasatch advisors lp7.06M0.10%-3.28M

New Positions

HolderShares% AssetsChangeValue
Aigh capital management3.00M2.24%3.00M$7.95M
Royce & associates lp2.29M0.06%2.29M$6.08M
Integral health asset management1.50M0.27%1.50M$3.98M
Logos global management lp750.00K0.18%750.00K$1.99M
Walleye capital319.19K0.00%319.19K$845.86K

Sold Out

HolderChange
Assetmark-8.00
True wealth design-22.00
Td waterhouse canada-59.00
Rothschild investment-100.00
Geowealth management-102.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025119-26.54%54,298,682-41.97%271.22%59-13.24%23-41.03%
Jun 30, 2025168-11.58%98,172,969-13.34%491.49%67-17.28%44-21.43%
Mar 31, 2025190-7.77%113,479,021-9.95%571.38%82-8.89%5621.74%
Dec 31, 202486-56.78%36,541,743-71.74%180.43%38-51.28%15-65.91%
Sep 30, 20241993.11%129,297,339-5.46%661.02%78-28.44%4457.14%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
BB Biotech AG Ord9.94M5.05%-
Wasatch Ultra Growth7.02M3.54%345.40K
Pender Corporate Bond F6.36M3.18%359.98K
Vanguard US Total Market Shares ETF6.18M3.12%-
Vanguard Total Stock Mkt Idx Inv6.05M3.02%-133.35K
iShares Russell 2000 ETF4.84M2.40%-
Wasatch Small Cap Growth Investor4.35M2.21%-43.99K
Nuveen Quant Small Cap Equity R62.46M1.24%-61.14K
Fidelity Small Cap Index1.99M0.99%67.05K
Vanguard Institutional Extnd Mkt Idx Tr1.96M0.98%-895.39K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 17, 2025Looker Benjamin General CounselSell$17.57K
Sep 17, 2025Koenig Sheldon L. President and CEOSell$79.25K
Sep 17, 2025Halladay Benjamin Chief Financial OfficerSell$19.79K
Jul 17, 2025Looker Benjamin General CounselSell$1.47K
Jul 17, 2025Halladay Benjamin Chief Financial OfficerSell$12.27

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q3-5
2025 Q2-5
2025 Q1-7
2024 Q4-5

ESPR Ownership FAQ

Who Owns Esperion Therapeutics?

Esperion Therapeutics shareholders are primarily institutional investors at 27.59%, followed by 0.44% insiders and 71.97% retail investors. The average institutional ownership in Esperion Therapeutics's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which Esperion Therapeutics exceeds.

Who owns the most shares of Esperion Therapeutics?

Esperion Therapeutics’s largest shareholders are Blackrock (13.98M shares, 8.26%), Blackrock funding, inc. /de (14.83M shares, 7.54%), and Vanguard group (12.09M shares, 6.14%). Together, they hold 21.94% of Esperion Therapeutics’s total shares outstanding.

Does Blackrock own Esperion Therapeutics?

Yes, BlackRock owns 8.26% of Esperion Therapeutics, totaling 13.98M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 31.04M$. In the last quarter, BlackRock increased its holdings by 11.14M shares, a 392.59% change.

Who is Esperion Therapeutics’s biggest shareholder by percentage of total assets invested?

Meditor group is Esperion Therapeutics’s biggest shareholder by percentage of total assets invested, with 15.57% of its assets in 3.79M Esperion Therapeutics shares, valued at 8.42M$.

Who is the top mutual fund holder of Esperion Therapeutics shares?

BB Biotech AG Ord is the top mutual fund holder of Esperion Therapeutics shares, with 5.05% of its total shares outstanding invested in 9.94M Esperion Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools